Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Corrigendum to "An investigation into the association between HLA-G 14bp insertion/deletion polymorphism and multiple sclerosis susceptibility" [Journal of Neuroimmunology 290 (2016) 115-118].
The role of the wnt canonical signaling in neurodegenerative diseases.
Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis.
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: A case report.
Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation.
Receipt of recommended services among patients with selected disabling conditions and diabetes.
Divided visual attention: A comparison of patients with multiple sclerosis and controls, assessed with an optokinetic nystagmus suppression task.
In Vivo Gene Transfer to Schwann Cells in the Rodent Sciatic Nerve by Electroporation.
Is my MS patient failing treatment?
Atypical inflammatory demyelinating syndromes of the CNS.
Deficiency in Mental Rotation of Upper and Lower-Limbs in Patients With Multiple Sclerosis and Its Relation With Cognitive Functions.
The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
Neuroprotective effects of various doses of topiramate against methylphenidate induced oxidative stress and inflammation in rat isolated hippocampus.
Influence of a low dose of silver nanoparticles on cerebral myelin and behavior of adult rats.
Characteristics of Children and Adolescents With Multiple Sclerosis.
Causality Analysis of Inertial Body Sensors for Multiple Sclerosis Diagnostic Enhancement.
Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.
Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial.
Pages
« first
‹ previous
…
746
747
748
749
750
751
752
753
754
…
next ›
last »